PloS one 2016, 11(1):e0146797 Valizadeh M, Valizadeh N
62 To date, 926 patients have been treated in a clinical setting (unpublished data, Rhythm Pharmaceuticals, Inc
I-vit 12 Injection is supplied as a injection and is taken by the parenteral route
GHK-Cu is a signaling peptide studied at low concentrations, so 0.10% sits within the range the research tradition works in rather than being a "trace." The most robust evidence is in wound-healing and lab research
Always measure the calculated volume precisely to achieve your intended concentration
Patients experiencing metabolic concerns should consult their GP or practice nurse for evidence-based treatment options, which may include lifestyle modifications and NICE-recommended pharmacological interventions where appropriate